Antoni Ribas, M.D., Ph.D.
Professor, Departments or Medicine, Surgery, and Molecular and Medical Pharmacology
Director, Parker Institute for Cancer Immunotherapy Center at UCLA
Director, JCCC Tumor Immunology Program
Member, JCCC Signal Transduction and Therapeutics Program
UCLA Jonsson Comprehensive Cancer Center
Los Angeles, California
ANTONI RIBAS, M.D., Ph.D. is Professor of Medicine, Professor of Surgery, and Professor of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA), Director of the Tumor Immunology Program at the Jonsson Comprehensive Cancer Center (JCCC) and the Chair of the Melanoma Committee at SWOG. Trained at the University of Barcelona, with postdoctoral research and clinical fellowships at UCLA. He is an elected member of the American Society of Clinical Investigation (ASCI) and is the recipient of a NCI Outstanding Investigator Award. Dr Ribas is a physician- scientist who conducts laboratory and clinical research in malignant melanoma, focusing on gene engineered adoptive cell transfer (ACT) therapies, anti-CTLA4 antibodies, anti-PD-1 antibodies, BRAF and MEK inhibitors and nanoparticle-siRNA. His NIH, State of California and private foundation-supported research laboratory develops models of disease to test new therapeutic options and studies mechanism of action of treatments in patients.